The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACCELERON PHARMA INC | COM | 00434H108 | 17,210 | 100,000 | SH | SOLE | 1 | 100,000 | 0 | 0 | |
| COLUMBIA PPTY TR INC | COM NEW | 198287203 | 7,967 | 418,870 | SH | SOLE | 1 | 418,870 | 0 | 0 | |
| KANSAS CITY SOUTHERN | COM NEW | 485170302 | 27,579 | 101,904 | SH | SOLE | 1 | 101,904 | 0 | 0 | |
| SHAW COMMUNICATIONS INC | CL B CONV | 82028K200 | 15,254 | 525,400 | SH | SOLE | 1 | 525,400 | 0 | 0 | |
| WELBILT INC | COM | 949090104 | 9,296 | 400,000 | SH | SOLE | 1 | 400,000 | 0 | 0 | |